EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
Turnover
42.86%
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
+5.57%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$6.13B
AUM Growth
+$505M
(+9%)
Cap. Flow
+$205M
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
831
New
162
Increased
239
Reduced
241
Closed
184
Avg Time Held
1.7
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VALT
ETFMG Sit Ultra Short ETF
VALT
|
+$79.6M |
| 2 |
Tilray
TLRY
|
+$56.8M |
| 3 |
Aurora Cannabis
ACB
|
+$54.4M |
| 4 |
Canopy Growth
CGC
|
+$51.6M |
| 5 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$187M |
| 2 |
APHA
Aphria Inc. Common Shares
APHA
|
+$182M |
| 3 |
Hecla Mining
HL
|
+$43.6M |
| 4 |
Mativ Holdings
MATV
|
+$21.5M |
| 5 |
BlackBerry
BB
|
+$21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.87% |
| 2 | Healthcare | 15.14% |
| 3 | Materials | 14.7% |
| 4 | Financials | 7.38% |
| 5 | Consumer Staples | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Bristol-Myers Squibb
BMY
$121B
| $999K | 0.02% |
15,075
-24,533
| -62% | -$1.6M |
2017 Q2
16 quarters
|
|
|
RADA
277
DELISTED
Rada Electronic Industries Ltd
RADA
| $992K | 0.02% |
82,449
-1,490
| -2% | -$18.3K |
2018 Q3
11 quarters
|
|
278
Merck
MRK
$363B
| $978K | 0.02% |
12,669
+3,016
| +31% | +$224K |
2019 Q2
8 quarters
|
|
279
NetEase
NTES
$79.2B
| $965K | 0.02% |
8,414
+5,761
| +217% | +$634K |
2018 Q3
11 quarters
|
|
280
Compugen
CGEN
$189M
| $944K | 0.02% |
113,284
-8,533
| -7% | -$69.3K |
2019 Q2
8 quarters
|
|
281
MarineMax
HZO
$1.16B
| $921K | 0.02% |
+19,051
| New | +$994K |
2021 Q2
0 quarters
|
|
282
AtriCure
ATRC
$2.92B
| $883K | 0.01% |
+11,132
| New | +$809K |
2021 Q2
0 quarters
|
|
283
Comstock Resources
CRK
$4.02B
| $883K | 0.01% |
+135,438
| New | +$780K |
2021 Q2
0 quarters
|
|
|
CONE
284
DELISTED
CyrusOne Inc Common Stock
CONE
| $854K | 0.01% |
11,720
-848
| -7% | -$61.8K |
2020 Q2
4 quarters
|
|
285
3D Systems Corp
DDD
$487M
| $841K | 0.01% |
21,897
-4,045
| -16% | -$107K |
2021 Q1
1 quarter
|
|
286
Fulgent Genetics
FLGT
$579M
| $824K | 0.01% |
+8,611
| New | +$688K |
2021 Q2
0 quarters
|
|
287
Molina Healthcare
MOH
$11B
| $823K | 0.01% |
3,206
-2,781
| -46% | -$699K |
2020 Q2
4 quarters
|
|
288
Ashford Hospitality Trust
AHT
$12M
| $822K | 0.01% |
+1,776
| New | +$644K |
2021 Q2
0 quarters
|
|
289
DELISTED
Apellis Pharmaceuticals
APLS
| $818K | 0.01% |
+12,899
| New | +$666K |
2021 Q2
0 quarters
|
|
|
DRNA
290
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $816K | 0.01% |
22,682
-697
| -3% | -$21.4K |
2020 Q2
4 quarters
|
|
291
BioCryst Pharmaceuticals
BCRX
$2.04B
| $812K | 0.01% |
52,412
-1,860
| -3% | -$25.3K |
2020 Q2
4 quarters
|
|
292
VNET Group
VNET
$1.29B
| $811K | 0.01% |
34,842
+3,171
| +10% | +$80.8K |
2020 Q2
4 quarters
|
|
|
ANAT
293
DELISTED
American National Group, Inc. Common Stock
ANAT
| $811K | 0.01% |
+5,569
| New | +$745K |
2021 Q2
0 quarters
|
|
294
Ameresco
AMRC
$1.07B
| $809K | 0.01% |
+12,354
| New | +$665K |
2021 Q2
0 quarters
|
|
295
Pool Corp
POOL
$5.73B
| $809K | 0.01% |
+1,740
| New | +$733K |
2021 Q2
0 quarters
|
|
296
Opko Health
OPK
$1.01B
| $806K | 0.01% |
197,656
-7,573
| -4% | -$29.7K |
2020 Q2
4 quarters
|
|
297
ChargePoint
CHPT
$180M
| $803K | 0.01% |
+1,125
| New | +$596K |
2021 Q2
0 quarters
|
|
298
Gartner
IT
$12.4B
| $800K | 0.01% |
+3,290
| New | +$720K |
2021 Q2
0 quarters
|
|
299
Gladstone Land Corp
LAND
$410M
| $791K | 0.01% |
+32,832
| New | +$743K |
2021 Q2
0 quarters
|
|
300
Idexx Laboratories
IDXX
$41.6B
| $777K | 0.01% |
1,220
-135
| -10% | -$74.5K |
2017 Q2
16 quarters
|
|
Similar funds
AIA
PFM
DKP
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q2 2021 Portfolio in Review
As of Q2 2021, ETF Managers Group held 831 positions worth $6.13B, up 9% from $5.63B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ETF Managers Group deployed $205M of net new capital in Q2 2021, opening 162 new positions and adding to 239 existing holdings. Its largest new stake was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 42% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Hecla Mining, an estimated $43.6M trimmed.
- ETF Managers Group's largest Q2 2021 buy was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
- ETF Managers Group added most to ETFMG Sit Ultra Short ETF in Q2 2021, an estimated $79.6M increase.
- ETF Managers Group's biggest Q2 2021 reduction was Hecla Mining, cutting an estimated $43.6M.
- ETF Managers Group fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $187M.
- ETF Managers Group's ten largest holdings make up 20% of its $6.13B portfolio in Q2 2021.
- ETF Managers Group opened 162 new positions and closed 184 in Q2 2021.
- ETF Managers Group's portfolio value rose 9% quarter-over-quarter to $6.13B.
Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.